Author(s):
Sarita Khushalrao Metangale, Om Nandkishor Bhandurge, Shatrughna U Nagrik, Shivshankar D. Mhaske
Email(s):
Saritametangalepatil@gmail.com
DOI:
10.52711/2231-5691.2026.00027 
Address:
Sarita Khushalrao Metangale¹, Om Nandkishor Bhandurge², Shatrughna U Nagrik³, Shivshankar D. Mhaske⁴
1,2Students of Bachelor of Pharmacy, Satyajeet College of Pharmacy, Khandala, Mehkar – 443301, Maharashtra
3Assistant Professor, Department of Pharmacology, Satyajeet College of Pharmacy, Khandala, Mehkar - 443301
4Principal, Satyajeet College of Pharmacy, Khandala, Mehkar – 443301, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2026
ABSTRACT:
High blood glucose levels caused by deficits in either insulin action or synthesis, or both, are a hallmark of diabetes mellitus, a chronic metabolic disorder. The two primary types of diabetes are Type 1 diabetes, an autoimmune condition that kills beta cells that make insulin, and Type 2 diabetes, which is mostly caused by insulin resistance and insufficient insulin production. Diabetes is becoming more and more common worldwide, mostly as a result of lifestyle choices like obesity, poor food, and inactivity. Diabetes can cause major side effects like blindness, kidney failure, neuropathy, and cardiovascular disease if it is not controlled. In order to lessen the burden of diabetes, preventive measures are essential. These consist of lifestyle changes such eating a healthy diet, exercising frequently, controlling one's weight, and identifying people who are at risk early. Fighting the rising diabetes epidemic requires public health programs that emphasize healthcare access, education, and awareness. This review summarizes the pathophysiology, risk factors, and preventative strategies of diabetes mellitus, emphasizing the importance of early intervention and lifestyle modifications.
Cite this article:
Sarita Khushalrao Metangale, Om Nandkishor Bhandurge, Shatrughna U Nagrik, Shivshankar D. Mhaske. Overview of Diabetes Mellitus and its Prevention. Asian Journal of Pharmaceutical Research. 2026; 16(2):179-6. doi: 10.52711/2231-5691.2026.00027
Cite(Electronic):
Sarita Khushalrao Metangale, Om Nandkishor Bhandurge, Shatrughna U Nagrik, Shivshankar D. Mhaske. Overview of Diabetes Mellitus and its Prevention. Asian Journal of Pharmaceutical Research. 2026; 16(2):179-6. doi: 10.52711/2231-5691.2026.00027 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2026-16-2-12
REFERENCE:
1. Baxtiyarovich AR, Hamzayevna NS. The Effects And Management Of Diabetes Mellitus. Yangi O Zbekiston, Yangi Tadqiqotlar Jurnali. 2025; 2(1): 90-2.
2. Qaid MM, Abdelrahman MM. Role of insulin and other related hormones in energy metabolism—A review. Cogent Food & Agriculture. 2016; 2(1):1267691.
3. Balaji R, Duraisamy R, Kumar MP. Complications of diabetes mellitus: A review. Drug Invention Today. 2019; 12(1).
4. Gogan A, Potre O, Avram VF, Andor M, Caruntu F, Timar B. Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications: A Narrative Review. Journal of Clinical Medicine. 2025; 14(3): 671.
5. Sayed Ahmed HA, Mohamed SF, Joudeh AI, Elotla SF, Mostafa M, Shah J, Fouad AM, Abdelazim SA. Combined symptoms of diabetes distress, depression, and anxiety and their association with glycemic control in primary care patients with type 2 diabetes in Egypt. Diabetology International. 2025 :1-3
6. Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018; 41(9):2026.
7. Alsheikh, H., Hazzazi, A., Alannaz, A., & Abualkhair, L. Association of Oral Health and Diabetes. Saudi J Oral Dent Res. 2025; 10(4): 205-209.
8. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å. Type 1 diabetes mellitus. Nature reviews Disease primers. 2017; 3(1):1-7.
9. Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatric Clinics. 2005; 52(6): 1553-78.
10. Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World Journal of Diabetes. 2014; 5(5): 689.
11. Reinehr T, Wabitsch M. Type 2 diabetes mellitus in children and adolescents. Prevention of type 2 diabetes. 2005:21-40.
12. Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013; 4(4): 46-57.
13. Grootenhuis PA, Snoek FJ, Heine RJ, Bouter LM. Development of a type 2 diabetes symptom checklist: a measure of symptom severity. Diabetic Medicine. 1994; 11(3): 253-61.
14. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994; 43(8): 1066-85.
15. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. The Lancet. 2011; 378(9786): 182-97.
16. Buchanan TA, Xiang AH. Gestational diabetes mellitus. The Journal of Clinical Investigation. 2005; 115(3): 485-91.
17. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care. 2007; 30(4): 878-83.
18. O’Sullivan JB. The Boston gestational diabetes studies: review and perspectives. Carbohydrate Metabolism in Pregnancy and the Newborn· IV. 1989: 287-94.
19. Cheung NW. The management of gestational diabetes. Vascular Health and Risk Management. 2009:153-64.
20. Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2019: 1047-56.
21. Rafique I, Mir A, Saqib MA, Naeem M, Marchand L, Polychronakos C. Causal variants in Maturity Onset Diabetes of the Young (MODY)–A systematic review. BMC Endocrine Disorders. 2021; 21: 1-6.
22. Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). Bmj. 2011; 343.
23. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia. 2005; 48: 2206-12.
24. Davies H, Brophy S, Fielding A, Bingley P, Chandler M, Hilldrup I, Brooks C, Williams R. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabetic Medicine. 2008; 25(11): 1354-7.
25. Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: a review on clinical implications and management. Diabetes & Metabolism Journal. 2018; 42(6): 451.
26. Irvine WJ. Classification of idiopathic diabetes. The Lancet. 1977; 309(8012): 638-42.
27. Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021; 2(2):36-50.
28. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB, Wilson PW, Savage PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004; 292(20): 2495-9.
29. John S. Complication in diabetic nephropathy. Diabetes & Metabolic Syndrome: Clinical Research and Reviews. 2016; 10(4): 247-9.
30. Ahamed MM, Banji O. A review on diabetic neuropathy and nephropathy. International Journal of Pharmaceutical Sciences and Research. 2012; 3(2):300.
31. Nentwich MM, Ulbig MW. Diabetic retinopathy-ocular complications of diabetes mellitus. World Journal of Diabetes. 2015; 6(3): 489.
32. Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections. Clinical Microbiology and Infection. 2015; 21:S27-32.
33. de Macedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetology and Metabolic Syndrome. 2016; 8: 1-8.
34. Nguyen AT, Akhter R, Garde S, Scott C, Twigg SM, Colagiuri S, Ajwani S, Eberhard J. The association of periodontal disease with the complications of diabetes mellitus. A systematic review. Diabetes Research and Clinical Practice. 2020; 165: 108244.
35. Samocha-Bonet D, Wu B, Ryugo DK. Diabetes mellitus and hearing loss: A review. Ageing Research Reviews. 2021; 71: 101423.
36. Hoban C, Sareen J, Henriksen CA, Kuzyk L, Embil JM, Trepman E. Mental health issues associated with foot complications of diabetes mellitus. Foot and Ankle Surgery. 2015; 21(1): 49-55.
37. Parkman HP, Wilson LA, Farrugia G, Koch KL, Hasler WL, Nguyen LA, Abell TL, Snape W, Clarke J, Kuo B, McCallum RW. Delayed gastric emptying associates with diabetic complications in diabetic patients with symptoms of gastroparesis. Official Journal of the American College of Gastroenterology, ACG. 2019; 114(11): 1778-94.
38. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014:95-105.
39. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Lévy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000; 119(5): 1324-32.
40. Bener A, Zirie M, Al-Rikabi A. Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croatian medical journal. 2005; 46(2).
41. Choi BC, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001; 44: 1221-31.
42. Smith Jr SC. Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine. 2007; 120(3): S3-11.
43. Mayer-Davis EJ, Costacou T. Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes. Current Diabetes Reports. 2001; 1(2):170-6.
44. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England Journal of Medicine. 2001; 345(11): 790-7.
45. Game FL, Jones AF. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Diabetes, Obesity and Metabolism. 2000; 2(2): 91-7.
46. Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. New England Journal of Medicine. 2000; 342(13): 905-12.
47. Smith Jr SC. Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine. 2007; 120(3): S3-11.
48. Cypryk K, Szymczak W, Czupryniak L, Sobczak M, Lewiński A. Gestational diabetes mellitus-an analysis of risk factors. Endokrynologia Polska. 2008; 59(5): 393-7.
49. Legro RS. Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America. 2001; 28(1): 99-109.
50. Chang SA. Smoking and type 2 diabetes mellitus. Diabetes and Metabolism Journal. 2012; 36(6):399.
51. Robinson DJ, Coons M, Haensel H, Vallis M, Yale JF, Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes and mental health. Canadian Journal of Diabetes.2018;42:S130-41.
52. Clark Jr CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. New England Journal of Medicine. 1995; 332(18): 1210-7.
53. Walker KZ, O’Dea K, Gomez M, Girgis S, Colagiuri R. Diet and exercise in the prevention of diabetes. Journal of Human Nutrition and Dietetics. 2010; 23(4): 344-52.
54. Gill JM, Cooper AR. Physical activity and prevention of type 2 diabetes mellitus. Sports Medicine. 2008; 38: 807-24.
55. Morisset AS, St‐Yves A, Veillette J, Weisnagel SJ, Tchernof A, Robitaille J. Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes/ Metabolism Research and Reviews. 2010; 26(1):17-25.
56. Tibbs TL, Haire-Joshu D. Avoiding high-risk behaviors: smoking prevention and cessation in diabetes care. Diabetes Spectrum. 2002; 15(3): 164-9.
57. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Annals of Internal Medicine. 2004; 140(3): 211-9.
58. Hamasaki H, Yanai H. Periodic health checkups reduce the risk of hospitalization in patients with type 2 diabetes. Frontiers in Clinical Diabetes and Healthcare. 2023; 4: 1087303.
59. Suman S, Saurabh S. Type 1 Diabetes Prevention and Treatment Utilizing Gene and Cell Replacement Therapy. Therapy. 2025; 6(1): 99-111.
60. Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of Internal Medicine. 2016; 164(11): 740-51.
61. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016; 39(11): 2065.
62. Athyros VG, Mikhailidis DP, Papageorgiou AA, Bouloukos VI, Pehlivanidis AN, Symeonidis AN, Elisaf M. Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease. Journal of Human Hypertension. 2004; 18(11): 781-8.
63. Regina I, Tong F. Overview of insulin: more than a hormone for controlling glucose level. Biomed Eng Commun. 2025; 4(2): 10.
64. Ahmad K. Insulin sources and types: a review of insulin in terms of its mode on diabetes mellitus. Journal of Traditional Chinese Medicine. 2014; 34(2): 234-7.
65. Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT. Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes and Metabolism. 2011; 37(3): 190-200.
66. Mannucci E, Monami M, Marchionni N. Short‐acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta‐analysis. Diabetes, Obesity and Metabolism.2009;11(1):53-9.
67. Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Catherine HY. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ. 2014; 349.
68. Rosskamp RH, Park G. Long-acting insulin analogs. Diabetes Care. 1999; 22: B109.
69. Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. (Ultra‐) long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2020; 11.
70. Dağaşan S, Erbaş O. Insulin structure, function and diabetes models in animals. Journal of Experimental and Basic Medical Sciences. 2020; 1(3): 96-101.
71. Mann E, Sunni M, Bellin MD. Secretion of insulin in response to diet and hormones. Pancreapedia: The Exocrine Pancreas Knowledge Base. 2020.
72. Steiner DF, Clark JL, Nolan C, Rubenstein AH, Margoliash E, Aten B, Oyer PE. Proinsulin and the biosynthesis of insulin. InRecent progress in hormone research. Proceedings of the 1968 Laurentian Hormone Conference. 1969; 25: 207-282.
73. Panchal A, Shah V, Upadhyay UM. Insulin drug delivery systems: a review. Int. J. Res. Pharm. Sci. 2011; 2: 484-92.
74. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37(12): 1595-607.
75. Rahman MS, Hossain KS, Das S, Kundu S, Adegoke EO, Rahman MA, Hannan MA, Uddin MJ, Pang MG. Role of insulin in health and disease: an update. International Journal of Molecular Sciences. 202; 22(12): 6403.